Novartis enters strategic partnership with Lonza to accelerate growth of biologics pipeline

in
  • Alliance enables Novartis to rapidly scale up development and production for rich biological pipeline, which accounts for a quarter of its development portfolio
  • Strong Novartis R&D capabilities coupled with Lonza's leadership in process development and manufacturing, provides ideal long-term partnership